MedPath

Bed Rest After Preterm Premature Rupture of the Membranes

Not Applicable
Completed
Conditions
Preterm Premature Rupture of Membrane
Interventions
Behavioral: complete bed rest
Behavioral: activity restriction
Registration Number
NCT03814278
Lead Sponsor
Centro Hospitalar Lisboa Norte
Brief Summary

Antepartum bed rest is widely prescribed after preterm premature rupture of the membranes (PPROM), although its effectiveness to prevent preterm birth has not been demonstrated. This pilot randomized controled trial (RCT) aims to access the impact of bed rest in maternal and neonatal outcomes in pregnancies complicated by premature rupture of the membranes.

Detailed Description

Aims - To access the impact of bed rest in latency time to delivery, chorioamnionitis incidence and other maternal and neonatal outcomes in pregnancies complicated by PPROM, thus enabling proper sample size calculation for future powered RCT.

Study population and Sample size - Eligible patients included those with single pregnancies with PPROM at 24+0-33+6 weeks of gestation who were admitted to and delivering at our tertiary center. PPROM was diagnosed on the basis of patient's history and sterile speculum examination with visualization of amniotic fluid pooling in the vagina and/or leaking from the cervical canal. Exclusion criteria included indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress), fetal malformations, multiple gestation, and maternal immunosuppressive disease. Considering future sample size calculation based upon assumed differences between groups regarding latency and infection, we aimed a sample of 30 participants.

Randomization - A pilot unblinded randomized controlled trial (RCT) in a 1:1 allocation ratio between two groups (complete bed rest versus activity restriction after PPROM). Simple random allocation sequence was generated by the investigators and implemented by sequentially numbered sealed envelopes. Participants were enrolled by physicians after hospital admission and written informed consent was obtained before randomization. The trial was conducted in a single tertiary center of the Portuguese national health system after approval by its ethical committee.

Statistical analysis - An intention-to-treat analysis was performed with a significance level of 5%.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
32
Inclusion Criteria
  • single pregnancies AND
  • PPROM at 24+0-33+6 weeks of gestation AND
  • admitted to our tertiary center.
Exclusion Criteria
  • indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress)
  • fetal malformations
  • multiple gestation
  • maternal immunosuppressive disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Complete bed restcomplete bed restParticipants on complete bed rest group kept antepartum confinement to bed with toileting restricted to bedpan use. Participants in this group received prophylactic subcutaneous enoxaparin (40mg/day).
Activity restriction groupactivity restrictionActivity restriction group had motion limited to bathroom privileges and walks to the ward canteen four times per day.
Primary Outcome Measures
NameTimeMethod
ChorioamnionitisFrom preterm premature rupture of the membranes until delivery, estimated average time of one week

Incidence of clinical chorioamnionitis (defined as maternal fever plus leukocytosis and CRP elevation, or as maternal fever plus any two of the following: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent amniotic fluid)

Latency timeFrom preterm premature rupture of the membranes until delivery, estimated average time of one week

Time between preterm premature rupture of the membranes and delivery, in days

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath